Add BrightSurf on Google Email

Science News for September 25, 1997


NIH Office Of Dietary Supplements Expands Research Support

The NIH Office of Dietary Supplements is expanding its research support for dietary supplements, with new grants focused on the role of antioxidants in preventing cataract development and intestinal supplementation of amino acids in infants. The ODS will also continue to fund five existing studies in various areas of health and disease.

SourceNIH/National Institutes of Health·DateSep 25, 1997

New Mechanism To Explain Carbon Monoxide Poisoning Identified

Researchers at the University of Pennsylvania have discovered a novel biochemical mechanism for carbon monoxide poisoning that may lead to new clinical approaches. The study reveals that CO binds to heme proteins, usurping nitric oxide and leading to tissue-damaging oxidants and free radicals.

SourceUniversity of Pennsylvania School of Medicine·JournalChemical Research in Toxicology·DateSep 25, 1997

American Association Of Cereal Chemists To Hold 82nd Annual Meeting

The American Association of Cereal Chemists' (AACC) 82nd Annual Meeting will take place in San Diego from October 12-16, featuring a technical program with topics such as blood glucose control, cereal carbohydrates, and sensory evaluation. Over 230 exhibitors will showcase the latest equipment and services.

SourceAmerican Phytopathological Society·DateSep 25, 1997
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Michelson, Morley, And Macromolecules Ready For Shuttle Launch Tonight

Scientists are using NASA's Michelson interferometer to study protein crystal growth in space, a method that may lead to new treatments for diseases. The device, which was originally used to test the existence of the luminiferous ether, is being repurposed to analyze how molecules assemble into crystals.

SourceNASA/Marshall Space Flight Center--Space Sciences Laboratory·DateSep 25, 1997

Pharmaceuticals Manufactured In Insect Larvae

Researchers have discovered a way to harness valuable proteins from nearly dead insect pests, producing high-quality pharmaceuticals in a more cost-effective manner. The HeRD system enables the mass production of these proteins, paving the way for the development of novel vaccine treatments and alternative pesticides.

SourceCornell University·JournalEntomophaga·DateSep 25, 1997